Stimulus and response during early pregnancy in the mouse

Molecular Signaling Regulating Endometrium-Blastocyst Crosstalk

Implantation of the embryo into the uterine endometrium is one of the most finely-regulated processes that leads to the establishment of a successful pregnancy. A plethora of factors are released in a time-specific fashion to synchronize the differentiation program of both the embryo and the endometrium. Indeed, blastocyst implantation in the uterus occurs in a limited time frame called the "window of implantation" (WOI), during which the maternal endometrium undergoes dramatic changes, collectively called "decidualization". Decidualization is guided not just by maternal factors (e.g., estrogen, progesterone, thyroid hormone), but also by molecules secreted by the embryo, such as chorionic gonadotropin (CG) and interleukin-1β (IL-1 β), just to cite few. Once reached the uterine cavity, the embryo orients correctly toward the uterine epithelium, interacts with specialized structures, called pinopodes, and begins the process of adhesion and invasion. All these events are guided by factors secreted by both the endometrium and the embryo, such as leukemia inhibitory factor (LIF), integrins and their ligands, adhesion molecules, Notch family members, and metalloproteinases and their inhibitors. The aim of this review is to give an overview of the factors and mechanisms regulating implantation, with a focus on those involved in the complex crosstalk between the blastocyst and the endometrium.

Mouse trophoblastic cells exhibit a dominant invasiveness phenotype over cancer cells

Invasion process occurs both in mammalian embryo implantation during development and malignant cancer cell metastasis. We investigated the interactions between trophoblasts and metastatic cancer cells and found the phenomenon that mouse trophoblastic cells invaded the monolayer of malignant cancer cells in vitro and appeared the general trait of invasiveness to more than 30 types of malignant cancer cell lines which were derived from different histological origins and with different invasive or metastatic potential. We further investigated the cellular and molecular changes in the process of mouse trophoblastic cells invading human ovarian cancer HO-8910 cells. The results show that the invasion of trophoblastic cells lead HO-8910 cells near mouse embryo to apoptosis, and expression of cell-cycle-related protein cyclinD1 and Ki-67 mRNA were steadily remained both in mouse blastocysts and human ovarian cancer HO-8910 cells, which in part explain the proliferation activities of these cells. Our study also shows that expression of some proteins including MMP-9, FAK and Integrinαvβ3 was changeable in trophoblastic cells and HO-8910 cells in the process of blastocyst invasion, which suggested temporal expression of these molecules may involved in the invasive behavior of trophoblasts cells to cancer cells.

Mouse models of implantation

The process of implantation, necessary for nearly all viviparous birth, consists of tightly regulated reactions including apposition of the blastocyst, attachment to the uterine epithelium and decidualization of the uterine stroma. In order for implantation to be successful, a reciprocal interaction between an implantation competent blastocyst and receptive uterus must be achieved. A more thorough understanding of the molecular mechanisms that regulate uterine receptivity and implantation is of clinical relevance to correct implantation failure and improve pregnancy rates. As molecular methodologies have evolved in recent times, the use of in vivo models to elucidate the molecular mechanisms involved in implantation has increased. The mouse has emerged as a powerful model to investigate implantation owing to the ability to control uterine physiology through exogenous stimuli, and more recently, the ability to manipulate gene expression. This review describes the evolution of the mouse as a model for understanding uterine implantation, including exciting new advances in this field, and describes a novel genetic pathway that can be elucidated from these models.

Life Cycle of Decidual Cells

The decisive events in the development of decidual cells (DC) are presented through examples of human and rodent decidua. Human decidua is formed by large decidual cells (LDC), endometrial granulated cells (eGC), and small decidual cells. The LDC form the main type of decidual membranes, which determine the morphological characteristics of the decidua as a tissue. Immediate precursor cells of LDC are located below the basement membrane of the uterine epithelium before and during implantation. At the next stage of differentiation, LDC acquire a spindle-like shape. Rodent LDC form an epithelium-like structure with gland properties at the terminal stage of differentiation. The single-cell structure of human decidua is a derivative of the epithelial organization of rodent decidua. Spindle-like rat LDC are characterized by a high level of protein, RNA, and DNA synthesis and by intensive proliferation. At the beginning of pregnancy, a cell proliferation predominates over cell loss. By Days 12-13 of rat pregnancy LDC loss reaches 80% per day. Terminally differentiated LDC (tLDC) disappear from decidua due to apoptosis. Apoptosis of tLDC and the exhaustion of their precursors account for the disappearance of LDC in the middle of rat pregnancy. Human term decidua is composed of living cells. Human LDC (hLDC) comprise the largest part of human decidual cells (hLDC). hLDC account for 60-90% of hDC but their relative amount can decrease to 35% in the case of significant cell loss under unfavorable conditions. A decrease of LDC is not accompanied by DC proliferation. The lack of ability of decidua to compensate for DC loss suggests DC is a growing type of cell population without cambial cells. LDC function largely by blebbing and budding. Human and rat endometrial granulated cells (eGC) are characterized by a low level of natural killer (NK) activity and a high level of natural suppressor (NS) activity. The combination of NK and NS properties is characteristic of the eGC immunoregulatory function. Other functions of decidua include control of inflammation and trophoblast growth and expansion in the uterus. The life span of decidual cells is limited by pregnancy.

Changes in RNA polymerase activity in isolated mouse uterine nuclei during the decidual cell reaction

The artificially stimulated decidual cell reaction has been used as a model to study changes occurring in the uterus at the time of implantation. Activities of RNA polymerases I, II and III were measured in uterine nuclei isolated from ovariectomized non-primed mice, hormonally primed mice, and hormonally primed mice following stimulation of the decidual cell reaction. Activities of all three RNA polymerases increased following hormonal priming of ovariectomized mice. In nuclei from stimulated uterine horns, activities of RNA polymerases I and III increased 9 h after stimulation of the decidual cell reaction and remained elevated through 21 h. RNA polymerase II activity did not change following stimulation of the decidual cell reaction. These changes in RNA polymerase activities occur at the time of increased histone modifications and may result from changes in the template capacity.

Cyclic adenosine monophosphate-induced changes in the surface morphology of diapausing blastocysts and the effects on implantation

Estrogen induces blastocyst implantation in diapausing female mice, increases uterine levels of adenyl cyclase and cyclic adenosine monphosphate (cylic AMP), and stimulates synthesis of ribonucleic acid and protein in both the uterus and blastocyst. Furthermore, the surface ultrastructure of trophoblast cells seen with scanning electron microscopy (SEM) changes with activation of the diapausing blastocyst by estrogen. Cyclic AMP-activated blastocysts were investigated with the use of SEM and compared to blastocysts activated by estrogen. Intraperitoneal administration of cyclic AMP was generally ineffective, whereas administration of cyclic AMP intraluminally in the uterus effectively mimicked the early estrogen activation. These findings are discussed in relation to other known activation changes in preimplantation blastocysts and with regard to similar findings after administration of various antiestrogens.

Inhibition of implantation in the golden hamster by zona-precipitating antibody

Antisera prepared against saline extracts of hamster ovary, and made specific to ovary by absorption with small intestine, precipitated the zona pellucida of provulatory hamster ova and all early embryonic stages examined, including the pronuclear, 2-, 4-, 8-, and 16-cell, morula, and blastocyst stages; this indicates that (1) the zona antigen is present during oocyte maturation and early embryonic development and (2) the antigen does not change its ability to react with zonaprecipitating antibody. Embryos in the morula and blastocyst stages, treated in vitro with zona-precipitating antibody, pre-immunization rabbit serum, or control media were transferred into synchronized pseudopregnant recipients. Precipitation of zonae by specific antibody inhibited implantation by blocking the process known as zona shedding, and thereby prevented the embryo from making contact with the uterus.

Implantation, transplantation, and epithelial-mesenchymal relationships in the rat uterus

Free tail skin grafts or suspensions of viable epidermal cells have been placed in the atraumatized uterus of isologous rat hosts and allowed to "implant" of their own accord to study the possible uniqueness of this site for other than nature's transplants, i.e. conceptuses, and its response to unnatural grafts. Despite the presence of an intact endometrial epithelium, free skin grafts heal-in rapidly, provided that a state of estrogen excess is established at the time of transplantation. In the absence of estrogen most of the grafts failed to implant. Once established, the grafts survive indefinitely without further estrogen. However, if at any stage a state of continual estrus is established, skin epidermis migrates centrifugally from the graft perimeter invasively replacing the native uterine epithelium. The results of an analysis of the modus operandi of this estrogen-facilitated epidermal migration in utero sustain the view that the hormone acts upon the uterine stroma rather than upon the epidermal cells. When grafts of lingual mucosa or vaginal "skin" were placed in the uteri of rats maintained in chronic estrus, migration of epidermis took place even more vigorously than from tail skin. These epithelia conserved their distinctive histologic specificities indefinitely when growing as heterotypic recombinants on the alien mesenchymal stroma of the uterus. Monodisperse suspensions of epidermal cells appear to "implant" and establish small epidermal plaques in the uterus only at sites predestined to accept conceptuses. That the endocrinologic parameters for the establishment of skin grafts in the uterus are similar to those for blastocysts is suggested by the finding that both kinds of graft can become established in the same uterine horn in the absence of exogenous hormones.